These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 26223323

  • 1. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors.
    Donders G, Bellen G, Neven P, Grob P, Prasauskas V, Buchholz S, Ortmann O.
    Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323
    [Abstract] [Full Text] [Related]

  • 2. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
    Donders G, Neven P, Moegele M, Lintermans A, Bellen G, Prasauskas V, Grob P, Ortmann O, Buchholz S.
    Breast Cancer Res Treat; 2014 Jun; 145(2):371-9. PubMed ID: 24718774
    [Abstract] [Full Text] [Related]

  • 3. Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
    Buchholz S, Mögele M, Lintermans A, Bellen G, Prasauskas V, Ortmann O, Grob P, Neven P, Donders G.
    Climacteric; 2015 Apr; 18(2):252-9. PubMed ID: 25427450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapy of bacterial vaginosis using exogenously-applied Lactobacilli acidophili and a low dose of estriol: a placebo-controlled multicentric clinical trial.
    Parent D, Bossens M, Bayot D, Kirkpatrick C, Graf F, Wilkinson FE, Kaiser RR.
    Arzneimittelforschung; 1996 Jan; 46(1):68-73. PubMed ID: 8821521
    [Abstract] [Full Text] [Related]

  • 7. The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections.
    Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G.
    BJOG; 2005 Feb; 112(2):234-40. PubMed ID: 15663590
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of ultra-low dose 0.005% estriol vaginal gel for the treatment of vulvovaginal atrophy in postmenopausal women with early breast cancer treated with nonsteroidal aromatase inhibitors: a phase II, randomized, double-blind, placebo-controlled trial.
    Hirschberg AL, Sánchez-Rovira P, Presa-Lorite J, Campos-Delgado M, Gil-Gil M, Lidbrink E, Suárez-Almarza J, Nieto-Magro C.
    Menopause; 2020 May; 27(5):526-534. PubMed ID: 32049923
    [Abstract] [Full Text] [Related]

  • 9. A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
    Sánchez-Rovira P, Hirschberg AL, Gil-Gil M, Bermejo-De Las Heras B, Nieto-Magro C.
    Oncologist; 2020 Dec; 25(12):e1846-1854. PubMed ID: 32459035
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection.
    Pendharkar S, Brandsborg E, Hammarström L, Marcotte H, Larsson PG.
    BMC Infect Dis; 2015 Jul 03; 15():255. PubMed ID: 26137971
    [Abstract] [Full Text] [Related]

  • 13. Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study.
    Vicariotto F, Del Piano M, Mogna L, Mogna G.
    J Clin Gastroenterol; 2012 Oct 03; 46 Suppl():S73-80. PubMed ID: 22955364
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
    Pfeiler G, Glatz C, Königsberg R, Geisendorfer T, Fink-Retter A, Kubista E, Singer CF, Seifert M.
    Climacteric; 2011 Jun 03; 14(3):339-44. PubMed ID: 21226657
    [Abstract] [Full Text] [Related]

  • 16. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials.
    Donders G, Bellen G, Donders F, Pinget J, Vandevelde I, Michiels T, Byamughisa J.
    Eur J Clin Microbiol Infect Dis; 2017 Apr 03; 36(4):731-738. PubMed ID: 27933401
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety.
    Weissenbacher ER, Donders G, Unzeitig V, Martinez de Tejada B, Gerber S, Halaška M, Špaček J, Fluomizin Study Group.
    Gynecol Obstet Invest; 2012 Apr 03; 73(1):8-15. PubMed ID: 22205034
    [Abstract] [Full Text] [Related]

  • 19. Lactobacillus plantarum P17630 for preventing Candida vaginitis recurrence: a retrospective comparative study.
    De Seta F, Parazzini F, De Leo R, Banco R, Maso GP, De Santo D, Sartore A, Stabile G, Inglese S, Tonon M, Restaino S.
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov 03; 182():136-9. PubMed ID: 25305660
    [Abstract] [Full Text] [Related]

  • 20. Is vaginal hyaluronic acid as effective as vaginal estriol for vaginal dryness relief?
    Stute P.
    Arch Gynecol Obstet; 2013 Dec 03; 288(6):1199-201. PubMed ID: 24178484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.